Effects of cholera toxin on innate and adaptive immunity and its application as an immunomodulatory agent.
about
Regulation of adaptive immunity; the role of interleukin-10Microbial manipulation of receptor crosstalk in innate immunityProphylactic administration of bacterially derived immunomodulators improves the outcome of influenza virus infection in a murine model.Suppression of dendritic cell activation by diabetes autoantigens linked to the cholera toxin B subunit.Cholera toxin impairs the differentiation of monocytes into dendritic cells, inducing professional antigen-presenting myeloid cells.AB toxins: a paradigm switch from deadly to desirableEffect of live Salmonella Ty21a in dextran sulfate sodium-induced colitisCholera-toxin suppresses carcinogenesis in a mouse model of inflammation-driven sporadic colon cancer.The B subunit of Escherichia coli heat-labile toxin alters the development and antigen-presenting capacity of dendritic cellsImmunostimulant adjuvant patch enhances humoral and cellular immune responses to DNA immunization.Phosphodiesterase 4 inhibition in the treatment of psoriasis, psoriatic arthritis and other chronic inflammatory diseases.Anthrax edema toxin induces maturation of dendritic cells and enhances chemotaxis towards macrophage inflammatory protein 3beta.In vivo and in vitro adjuvant activities of the B subunit of Type IIb heat-labile enterotoxin (LT-IIb-B5) from Escherichia coli.Cholera toxin inhibits IL-12 production and CD8alpha+ dendritic cell differentiation by cAMP-mediated inhibition of IRF8 function.Mechanisms of Cholera Toxin in the Modulation of TH17 Responses.Heat-labile enterotoxins as adjuvants or anti-inflammatory agents.Mucosal adjuvants and long-term memory development with special focus on CTA1-DD and other ADP-ribosylating toxins.Cholera-like enterotoxins and Regulatory T cells.Macrophage-targeted therapy: CD64-based immunotoxins for treatment of chronic inflammatory diseases.Type II heat-labile enterotoxins: structure, function, and immunomodulatory properties.Nanoparticle based-immunotherapy against allergy.Cholera toxin B induced activation of murine macrophages exposed to a fixed bacterial immunogen.Increased antigen specific T cell numbers in the absence of altered migration or division rates as a result of mucosal cholera toxin administration.Gene expression profiling identifies STAT3 as a novel pathway for immunomodulation by cholera toxin adjuvant.Cholera toxin B subunit promotes the induction of regulatory T cells by preventing human dendritic cell maturation.Adjuvant selection regulates gut migration and phenotypic diversity of antigen-specific CD4(+) T cells following parenteral immunization.Purification and characterization of Yersinia enterocolitica and Yersinia pestis LcrV-cholera toxin A(2)/B chimeras.Cholera toxin enhances IL-17A production in both CD4+ and CD8+ cells via a cAMP/PKA-mediated IL-17A promoter activation.Adjuvant requirement for successful immunization with recombinant derivatives of Plasmodium vivax merozoite surface protein-1 delivered via the intranasal route.Is the choice of vaccine adjuvant critical for long-term memory development?Prostaglandin E2 is a negative regulator on human plasmacytoid dendritic cells.Association between post-diagnostic use of cholera vaccine and risk of death in prostate cancer patients.
P2860
Q21131215-F513A2F2-846D-40F0-957A-179E77DAE59DQ30499616-94B0396B-CC53-4C33-8FFF-EE567352BD0BQ33676552-3F804215-CB3F-4384-93DD-FDA24194E6A7Q34629092-D876001B-0DCA-49C5-9F54-C57CB4ED25BCQ34739851-1E949AB1-FC44-43F4-8994-1F17CE409F1AQ35155875-43DF39CC-152B-49C9-A2B1-44447FDA383EQ35161765-58918674-2691-469A-9DD4-2FF10039FA22Q35473462-B5699068-9DE1-4725-827F-232000CCA3ABQ35995130-1955160C-9D67-49F9-8598-CF09753B5CB9Q36782184-39FFDEFB-4BC9-4C95-8045-354837F2E56DQ36923514-D359F683-9887-495E-A828-F28A99A6C264Q37191376-0FF8F6B5-31A4-434B-8D68-F76DC6E6E7F4Q37238638-085C3A82-F14A-47F9-A993-53010A7105B7Q37273216-F4F8ECB3-401C-478F-9AFF-4471F6D9EA04Q37641941-DF417E80-5D6B-42B4-89E0-C9FEDA263A27Q37749719-32D1FF01-ACA6-4CE2-9500-987B5737A15AQ37789144-6145AE07-F49C-42ED-96BF-62E389A6B241Q37954306-4CBC4429-B80C-4ADF-BF0E-724B832532F1Q38056128-E31921D1-23DF-43F7-9484-851D0C3C2FA7Q38058640-B8930AE4-A050-49AB-A317-13BAFC9DA492Q38257645-320EE974-3FD8-4E99-A8F6-309C37614B74Q38811704-8ECF6BFE-18BF-43A0-BAB6-E53A6466913BQ39357136-9CBBE4ED-5DB2-485C-AC32-51F9FCC2F0CCQ39717371-EFB13E6E-30E6-4747-9047-F2B5B04A032CQ39971245-795101C8-0C84-42E4-B1DC-08B6586AEFC3Q40100679-923E5A64-C573-4122-8609-05F3ACD15799Q41434206-B4336B4C-520B-4DEF-9CA0-295FBBB27A87Q47645568-F9E91EEA-1B30-4700-9D39-FEA651A90004Q47835607-4F0A7465-0B05-44AF-831A-79A486D3501BQ51029620-96F14665-479D-442B-865F-FD2008F29CE8Q54597829-F8196878-9736-4DD7-856E-548C9FEF806CQ55285043-CD6DD70A-62F4-458D-813A-4EBFAAB9FDE6
P2860
Effects of cholera toxin on innate and adaptive immunity and its application as an immunomodulatory agent.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Effects of cholera toxin on in ...... as an immunomodulatory agent.
@ast
Effects of cholera toxin on in ...... as an immunomodulatory agent.
@en
type
label
Effects of cholera toxin on in ...... as an immunomodulatory agent.
@ast
Effects of cholera toxin on in ...... as an immunomodulatory agent.
@en
prefLabel
Effects of cholera toxin on in ...... as an immunomodulatory agent.
@ast
Effects of cholera toxin on in ...... as an immunomodulatory agent.
@en
P2093
P2860
P356
P1476
Effects of cholera toxin on in ...... as an immunomodulatory agent.
@en
P2093
Andrew Jarnicki
Edel McNeela
Kingston H G Mills
Olive Leavy
Sarah C Higgins
P2860
P304
P356
10.1189/JLB.1103534
P577
2004-01-02T00:00:00Z